Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

2.300 -0.110 (-4.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 343,486
Open 2.370
Bid (Size) 2.300 (63)
Ask (Size) 2.440 (2)
Prev. Close 2.410
Today's Range 2.300 - 2.500
52wk Range 1.790 - 8.940
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
Via ACCESS Newswire
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC)... 
From Medicus Pharma
Via GlobeNewswire

Performance

YTD
-8.4%
-8.4%
1 Month
-8.4%
-8.4%
3 Month
-11.2%
-11.2%
6 Month
-42.6%
-42.6%
1 Year
-13.2%
-13.2%

More News

Read More
4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA)
Via AB Newswire
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Via ACCESS Newswire
4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH)
Via AB Newswire
Three Biotech Companies Redefining Value Creation Through Dual Strategies
Via ACCESS Newswire
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Via ACCESS Newswire
Medicus Pharma (Nasdaq: MDCX) Nears Surgery-Free Breakthrough in Oncology
Via AB Newswire
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
Via ACCESS Newswire
Medicus Pharma (Nasdaq: MDCX) Bringing Scar-Free, Outpatient Treatment to an $8 Billion Cancer Market
Via AB Newswire
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
Via ACCESS Newswire
Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics
Via News Direct
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics (MDCX, PRTC, RANI, INO)
Via AB Newswire
Stonegate Capital Partners Initiates Coverage on Medicus Pharma Ltd. (MDCX)
Via Newsfile
Medicus Pharma Ltd. To Present at Brookline Capital Markets
Via ACCESS Newswire
4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)
Via News Direct
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing
Via ACCESS Newswire
4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)
Via AB Newswire
Biotech Movers: Four Companies Making Big Strides in Innovation and Growth (MDCX, ARQT, CRMD, MCXT)
Via News Direct
Biotech Movers: Four Companies Making Big Strides in Innovation and Growth (MDCX, ARQT, CRMD, MCXT)
Via AB Newswire
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Via ACCESS Newswire
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
Via AB Newswire
Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
Via News Direct
Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)
Via AB Newswire

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 2.300
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 10/29/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.